Australia markets closed

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.02-0.01 (-0.17%)
At close: 04:00PM EDT
6.02 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPS1.121.1N/AN/A
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate62.83M64.51M258.29M224.81M
Low estimate62.83M64.51M258.29M224.81M
High estimate62.83M64.51M258.29M224.81M
Year ago sales62.08M60.7M316.61M258.29M
Sales growth (year/est)1.20%6.30%-18.40%-13.00%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS0.910.831.051.05
Actual EPS1.121.11.261.18
Difference0.210.270.210.13
Surprise %23.10%32.50%20.00%12.40%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate0000
7 days ago1.091.074.693.48
30 days ago1.091.074.693.48
60 days ago1.091.074.693.48
90 days ago1.091.074.693.48
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEGRXIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)11.34%N/AN/AN/A